| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | 0.4 | 8.8 |
| Net income | -5.1 | 4.7 |
| EPS (diluted, $ a share) | $-1.29 | $4.26 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -95.9% |
|---|
Source
Read the filing ↗
10-Q filed with the SEC, NASDAQ: PTN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Palatin Technologies Inc: key numbers
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.